Optinose_logo_RGB.png
Peter Miller Named Frank Baldino Bioscience CEO of the Year by Life Sciences Pennsylvania
20 févr. 2018 16h01 HE | OptiNose, Inc.
YARDLEY, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...